Electromed (NYSE:ELMD) Announces Quarterly Earnings Results

Electromed (NYSE:ELMD) issued its earnings results on Tuesday. The company reported $0.16 EPS for the quarter, beating the consensus estimate of $0.03 by $0.13, Zacks reports. The company had revenue of $14.67 million during the quarter. Electromed had a net margin of 11.34% and a return on equity of 15.32%.

Electromed Stock Performance

Shares of Electromed stock traded down $0.01 during trading on Friday, reaching $28.88. 21,488 shares of the company’s stock were exchanged, compared to its average volume of 41,427. The firm’s 50-day moving average price is $21.67 and its 200 day moving average price is $17.65. The company has a market cap of $244.32 million, a P/E ratio of 38.60 and a beta of 0.27. Electromed has a 1-year low of $9.81 and a 1-year high of $30.00.

About Electromed

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.